Wollenberg, A.

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 2,110

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 1,181

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 684

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J. ‐., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., et al. (2021) · British Journal of Dermatology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 638

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., et al. (2017) · New England Journal of Medicine

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 592

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Simpson, E. L., Sinclair, R., Forman, S., Wollenberg, A., Aschoff, R., Cork, M., Bieber, T., Thyssen, J. P., Yosipovitch, G., Flohr, C., et al. (2020) · The Lancet

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 522

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Wollenberg, A., Christen‐Zäch, S., Taieb, A., Paul, C., Thyssen, J. P., de Bruin‐Weller, M., Vestergaard, C., Seneschal, J., Werfel, T., Cork, M. J., et al. (2020) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 493

Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI).

Bieber, T., de la Salle, H., Wollenberg, A., Hakimi, J., Chizzonite, R., Ring, J., Hanau, D., & de la Salle, C. (1992) · The Journal of experimental medicine

Mast cells and histamineMonoclonal and Polyclonal Antibodies Research

Cited by 481

Conjunctivitis in dupilumab clinical trials

Akinlade, B., Guttman‐Yassky, E., Bruin‐Weller, M., Simpson, E. L., Blauvelt, A., Cork, M. J., Prens, E., Asbell, P., Akpek, E., Corren, J., et al. (2019) · British Journal of Dermatology

Dermatology and Skin DiseasesOcular Surface and Contact Lens

Cited by 442

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

Simpson, E. L., Lacour, J. ‐., Spelman, L., Galimberti, R., Eichenfield, L. F., Bissonnette, R., King, B. A., Thyssen, J. P., Silverberg, J. I., Bieber, T., et al. (2020) · British Journal of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 396

Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

Ständer, S., Yosipovitch, G., Legat, F. J., Lacour, J.-P., Paul, C., Narbutt, J., Bieber, T., Misery, L., Wollenberg, A., Reich, A., et al. (2020) · New England Journal of Medicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 281

Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus

Silverberg, J. I., Pinter, A., Pulka, G., Poulin, Y., Bouaziz, J.-D., Wollenberg, A., Murrell, D. F., Alexis, A., Lindsey, L., Ahmad, F., et al. (2020) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 271

Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe: PO-SCORAD self-assessment scale validation

Stalder, J.-F., Barbarot, S., Wollenberg, A., Holm, E. A., De Raeve, L., Seidenari, S., Oranje, A., Deleuran, M., Cambazard, F., Svensson, A., et al. (2011) · Allergy

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 255

Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

Kabashima, K., Furue, M., Hanifin, J. M., Pulka, G., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Nakano, M., & Ruzicka, T. (2018) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 248

Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation

Lichtenberger, B. M., Gerber, P. A., Holcmann, M., Buhren, B. A., Amberg, N., Smolle, V., Schrumpf, H., Boelke, E., Ansari, P., Mackenzie, C., et al. (2013) · Science Translational Medicine

Chemotherapy-related skin toxicityDermatology and Skin Diseases

Cited by 241

Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc ε RI

Jürgens, M., Wollenberg, A., Hanau, D., de la Salle, H., & Bieber, T. (1995) · The Journal of Immunology

Dermatology and Skin DiseasesMast cells and histamine

Cited by 146

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Chalmers, J. R., Simpson, E., Apfelbacher, C. J., Thomas, K. S., Kobyletzki, L., Schmitt, J., Singh, J. A., Svensson, Å., Williams, H. C., Abuabara, K., et al. (2016) · British Journal of Dermatology

Dermatology and Skin DiseasesDelphi Technique in Research

Cited by 125

Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREAT germany

Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Wollenberg, A., Weisshaar, E., Augustin, M., Wiemers, F., Zink, A., et al. (2020) · British Journal of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 53

Skin barrier function assessment: Electrical impedance spectroscopy is less influenced by daily routine activities than transepidermal water loss

Huygen, L., Thys, P. M., Wollenberg, A., Gutermuth, J., & Krohn, I. K. (2024) · Annals of Dermatology

Dermatology and Skin DiseasesAdvancements in Transdermal Drug Delivery

Cited by 23

A large language model artificial intelligence for patient queries in atopic dermatitis

Sulejmani, P., Negris, O., Aoki, V., Chu, C., Eichenfield, L., Misery, L., Mosca, A., Orfali, R. L., Aroman, M. S., Stalder, J., et al. (2024) · Journal of the European Academy of Dermatology and Venereology

Artificial Intelligence in Healthcare and EducationDermatology and Skin Diseases

Cited by 20

European Task Force on Atopic Dermatitis (ETFAD) Position Paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period

Vestergaard, C., Wollenberg, A., & Thyssen, J. P. (2020) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesPregnancy and Medication Impact

Cited by 13